Judith M. Bliss

Research interests

Publications

• Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

  Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.09.159

• Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)30932-6

• Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30444-7

• Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

  The Lancet · 2019 · 10.1016/s0140-6736(18)33137-4

• Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

  JAMA Oncology · 2019 · https://doi.org/10.1001/jamaoncol.2019.1838

• Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-03215-x

• Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

  Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0009-7

• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30777-5

• Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

  The Lancet · 2017 · 10.1016/s0140-6736(17)31145-5

• Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.67.3061

• The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

  The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70386-3

• Dissecting the Heterogeneity of Triple-Negative Breast Cancer

  Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.38.2010

• Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70149-8

• Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.1274

• Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

  The Lancet · 2007 · 10.1016/s0140-6736(07)60200-1

• Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

  The Lancet Oncology · 2007 · 10.1016/s1470-2045(07)70003-7

• Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

  The Lancet Oncology · 2006 · 10.1016/s1470-2045(06)70699-4

• A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050434

• Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial

  Radiotherapy and Oncology · 2005 · 10.1016/j.radonc.2005.01.005

• A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

  New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa040331

• Excision Margins in High-Risk Malignant Melanoma

  New England Journal of Medicine · 2004 · 10.1056/nejmoa030681

• Influence of psychological response on survival in breast cancer: a population-based cohort study

  The Lancet · 1999 · 10.1016/s0140-6736(98)11392-2

• Adjuvant psychological therapy for patients with cancer: a prospective randomised trial.

  BMJ · 1992 · 10.1136/bmj.304.6828.675

• Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

  BMJ · 1992 · 10.1136/bmj.304.6838.1343

• The Factor Structure and Factor Stability of the Hospital Anxiety and Depression Scale in Patients with Cancer

  The British Journal of Psychiatry · 1991 · 10.1192/bjp.158.2.255

Current projects

No projects listed.